• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: Cognex Corporation filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

    2/19/26 4:06:11 PM ET
    $CGNX
    Industrial Machinery/Components
    Industrials
    Get the next $CGNX alert in real time by email
    cgnx-20251029
    0000851205TRUE00008512052025-10-292025-10-29

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    ___________________________________
    FORM 8-K/A
    (Amendment No. 1)
    ___________________________________
    CURRENT REPORT
    Pursuant to Section 13 or 15(d)
    of the Securities Exchange Act of 1934

    Date of Report (date of earliest event reported): October 29, 2025
    ___________________________________
    Cognex Corporation
    (Exact name of registrant as specified in its charter)
    ___________________________________

    Massachusetts
    (State or other jurisdiction of
    incorporation or organization)
    001-34218
    (Commission File Number)
    04-2713778
    (I.R.S. Employer Identification Number)
    One Vision Drive
    Natick, Massachusetts 01760
    (Address of principal executive offices and zip code)
    (508) 650-3000
    (Registrant's telephone number, including area code)
    ___________________________________
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each class
    Trading Symbol
    Name of each exchange on which registered
    Common stock, par value $.002 per share
    CGNX
    The NASDAQ Stock Market LLC
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company    ☐



    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



    Explanatory Note

    Cognex Corporation (the “Company”) is filing this Amendment No. 1 to its Current Report on Form 8-K (the “Original Form 8-K”) filed with the Securities and Exchange Commission (the “Commission”) on November 3, 2025, to report that Grant Thornton LLP (“GT”) has completed its audit services for the fiscal year ended December 31, 2025 and to update the disclosures required by Item 304 of Regulation S-K through the effective date of GT’s dismissal. As disclosed in the Original Form 8-K, KPMG LLP (“KPMG”) was selected as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2026.

    Item 4.01 - Changes in Registrant’s Certifying Accountant

    On October 29, 2025, the Audit Committee of the Board of Directors of the Company notified GT, the Company’s then independent registered public accounting firm, that the Audit Committee selected KPMG as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2026, subject to completion of KPMG’s standard client acceptance procedures and execution of an engagement letter. GT was previously engaged to audit the Company’s consolidated financial statements for the fiscal year ending December 31, 2025. The appointment of KPMG did not affect GT’s engagement for the fiscal year ending December 31, 2025. GT was dismissed as the Company’s independent registered public accounting firm upon completion of its audit services on February 13, 2026.

    GT’s reports on the Company’s consolidated financial statements as of and for the fiscal years ended December 31, 2025 and 2024 did not contain any adverse opinion or disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope, or accounting principles. Further, during the fiscal years ended December 31, 2025 and 2024, and the subsequent interim period through February 13, 2026, there were: (i) no disagreements within the meaning of Item 304(a)(1)(iv) of Regulation S-K and the related instructions between the Company and GT on any matters of accounting principles or practices, financial statement disclosure, or auditing scope or procedure which, if not resolved to GT’s satisfaction, would have caused GT to make reference thereto in their reports; and (ii) no “reportable events” within the meaning of Item 304(a)(1)(v) of Regulation S-K.

    The Company requested that GT furnish a letter addressed to the Commission stating whether it agrees with the above statements. A copy of GT’s letter, dated February 19, 2026, is filed as Exhibit 16.1 to this Amendment No. 1 to Form 8-K.

    During the fiscal years ended December 31, 2025 and 2024 and the subsequent interim period through February 13, 2026, neither the Company nor anyone on its behalf has consulted with KPMG regarding: (i) the application of accounting principles to a specific transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company's financial statements, and neither a written report nor oral advice was provided to the Company that KPMG concluded was an important factor considered by the Company in reaching a decision as to any accounting, auditing, or financial reporting issue; (ii) any matter that was the subject of a disagreement within the meaning of Item 304(a)(1)(iv) of Regulation S-K and the related instructions; or (iii) any reportable event within the meaning of Item 304(a)(1)(v) of Regulation S-K.

    Item 9.01 - Financial Statements and Exhibits
    (d) Exhibits

    Exhibit No.
    Description
    16.1
    Letter from Grant Thornton LLP
    104
    Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)



    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 19th day of February, 2026.



    COGNEX CORPORATION
    By:
    /s/ Dennis Fehr
    Name:
    Dennis Fehr
    Title:
    Senior Vice President of Finance and Chief Financial Officer

    Get the next $CGNX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CGNX

    DatePrice TargetRatingAnalyst
    2/17/2026$68.00Hold → Buy
    HSBC Securities
    12/16/2025$50.00Sell → Buy
    Goldman
    12/3/2025$35.00Neutral → Underweight
    Analyst
    10/8/2025$55.00Overweight
    Barclays
    9/15/2025$45.00Neutral
    Analyst
    8/1/2025$50.00Sector Weight → Overweight
    KeyBanc Capital Markets
    7/10/2025$60.00Hold → Buy
    Melius
    4/28/2025$35.00Hold → Buy
    TD Cowen
    More analyst ratings

    $CGNX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cognex upgraded by HSBC Securities with a new price target

    HSBC Securities upgraded Cognex from Hold to Buy and set a new price target of $68.00

    2/17/26 8:01:33 AM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    Cognex upgraded by Goldman with a new price target

    Goldman upgraded Cognex from Sell to Buy and set a new price target of $50.00

    12/16/25 8:25:06 AM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    Cognex downgraded by Analyst with a new price target

    Analyst downgraded Cognex from Neutral to Underweight and set a new price target of $35.00

    12/3/25 8:29:41 AM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    $CGNX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cognex Announces Participation at the Raymond James 47th Annual Institutional Investors Conference

    NATICK, Mass., Feb. 18, 2026 /PRNewswire/ -- Cognex Corporation (NASDAQ:CGNX), the global technology leader in industrial machine vision, today announced that its President and Chief Executive Officer, Matt Moschner, is scheduled to present at the Raymond James 47th Annual Institutional Investors Conference in Orlando, Florida on Monday, March 2, 2026, at 11:00 a.m. Eastern Standard Time. The live webcast and subsequent replay can be accessed from Cognex's Investor Relations website at www.cognex.com/investor.About Cognex Corporation For over 40 years, Cognex has been making adv

    2/18/26 8:00:00 AM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    Cognex Appoints Sami Atiya and Chris Donato to Board of Directors

    NATICK, Mass., Feb. 17, 2026 /PRNewswire/ -- Cognex Corporation (NASDAQ:CGNX), ("Cognex"), the global technology leader in industrial machine vision, today announced the appointments of Dr. Sami Atiya and Mr. Chris Donato to Cognex's Board of Directors (the "Board"), effective March 2, 2026.  "We are excited to welcome Sami and Chris to our Board," said Matt Moschner, President and CEO. "We remain focused on our strategic objectives of becoming the leading provider of AI technology for industrial machine vision, delivering the best customer experience in our industry and doublin

    2/17/26 8:00:00 AM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    Cognex Reports Fourth Quarter 2025 Results

    NATICK, Mass., Feb. 11, 2026 /PRNewswire/ -- Cognex Corporation (NASDAQ:CGNX), the global technology leader in industrial machine vision, today reported financial results for the fourth quarter and full year 2025. Fourth-Quarter and Full-Year Financial and Operating Highlights Fourth-quarter revenue grew 10% year over year or 9% on a constant-currency basis.Full-year revenue grew 9% year over year or 8% on a constant-currency basis; excluding the one-time benefit from the commercial partnership with a medical lab automation channel partner (the "Commercial Partnership" or "CP"

    2/11/26 4:30:00 PM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    $CGNX
    SEC Filings

    View All

    Amendment: Cognex Corporation filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

    8-K/A - COGNEX CORP (0000851205) (Filer)

    2/19/26 4:06:11 PM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    Cognex Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - COGNEX CORP (0000851205) (Filer)

    2/17/26 8:01:37 AM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    SEC Form 10-K filed by Cognex Corporation

    10-K - COGNEX CORP (0000851205) (Filer)

    2/12/26 6:14:45 AM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    $CGNX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Parrotte Dianne M converted options into 8,324 shares, increasing direct ownership by 38% to 30,518 units (SEC Form 4)

    4 - COGNEX CORP (0000851205) (Issuer)

    2/19/26 5:02:11 PM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    CEO & President Moschner Matthew converted options into 5,085 shares and covered exercise/tax liability with 1,600 shares, increasing direct ownership by 42% to 11,847 units (SEC Form 4)

    4 - COGNEX CORP (0000851205) (Issuer)

    2/19/26 4:59:29 PM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    SVP, Chief Financial Officer Fehr Dennis converted options into 5,085 shares and covered exercise/tax liability with 1,618 shares, increasing direct ownership by 38% to 12,578 units (SEC Form 4)

    4 - COGNEX CORP (0000851205) (Issuer)

    2/19/26 4:56:26 PM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    $CGNX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Chief Financial Officer Fehr Dennis bought $249,920 worth of shares (6,570 units at $38.04) (SEC Form 4)

    4 - COGNEX CORP (0000851205) (Issuer)

    9/5/24 5:36:04 PM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    Director Parrotte Dianne M bought $77,230 worth of shares (2,000 units at $38.62), increasing direct ownership by 21% to 11,340 units (SEC Form 4)

    4 - COGNEX CORP (0000851205) (Issuer)

    8/8/24 4:21:53 PM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    $CGNX
    Leadership Updates

    Live Leadership Updates

    View All

    Cognex Appoints Sami Atiya and Chris Donato to Board of Directors

    NATICK, Mass., Feb. 17, 2026 /PRNewswire/ -- Cognex Corporation (NASDAQ:CGNX), ("Cognex"), the global technology leader in industrial machine vision, today announced the appointments of Dr. Sami Atiya and Mr. Chris Donato to Cognex's Board of Directors (the "Board"), effective March 2, 2026.  "We are excited to welcome Sami and Chris to our Board," said Matt Moschner, President and CEO. "We remain focused on our strategic objectives of becoming the leading provider of AI technology for industrial machine vision, delivering the best customer experience in our industry and doublin

    2/17/26 8:00:00 AM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    Cognex Appoints Greer Aviv as Head of Investor Relations

    NATICK, Mass., May 29, 2025 /PRNewswire/ -- Cognex Corporation (NASDAQ:CGNX), the global technology leader in industrial machine vision, today announced the appointment of Greer Aviv as Head of Investor Relations, effective June 2, 2025. Ms. Aviv will lead the company's investor relations strategy and communications, serving as the primary liaison between Cognex and the investment community. She will be responsible for articulating the company's vision, financial performance, and strategic direction to shareholders, analysts, and other key stakeholders. Ms. Aviv has an extensi

    5/29/25 6:00:00 AM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    Cognex Names Dennis Fehr as Chief Financial Officer

    NATICK, Mass., May 2, 2024 /PRNewswire/ -- Cognex Corporation (NASDAQ:CGNX), a leading provider of machine vision for factory and warehouse automation, today announced the appointment of Dennis Fehr as Senior Vice President of Finance and Chief Financial Officer, effective May 3, 2024. In this role, Fehr will lead Cognex's global finance and information technology organizations. Fehr brings over 20 years of global experience across manufacturing, technology, and energy industries. Most recently, Fehr was the CFO of 6K Inc, a manufacturing technology company focused on strategi

    5/2/24 6:00:00 AM ET
    $CGNX
    $FLNC
    Industrial Machinery/Components
    Industrials
    Miscellaneous

    $CGNX
    Financials

    Live finance-specific insights

    View All

    Cognex Reports Fourth Quarter 2025 Results

    NATICK, Mass., Feb. 11, 2026 /PRNewswire/ -- Cognex Corporation (NASDAQ:CGNX), the global technology leader in industrial machine vision, today reported financial results for the fourth quarter and full year 2025. Fourth-Quarter and Full-Year Financial and Operating Highlights Fourth-quarter revenue grew 10% year over year or 9% on a constant-currency basis.Full-year revenue grew 9% year over year or 8% on a constant-currency basis; excluding the one-time benefit from the commercial partnership with a medical lab automation channel partner (the "Commercial Partnership" or "CP"

    2/11/26 4:30:00 PM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    Cognex Announces Fourth Quarter 2025 Earnings Release and Conference Call Dates

    NATICK, Mass., Jan. 15, 2026  /PRNewswire/ -- Cognex Corporation (NASDAQ:CGNX), the global technology leader in industrial machine vision, will release earnings for the fourth quarter of 2025 on Wednesday, February 11, 2026, after market close. The Company will host a conference call on Thursday, February 12, 2026, at 8:30 a.m. Eastern Standard Time (EST), to discuss the results. Access to the conference call, and a replay that will be available following the call, may be found on the Cognex Investor Relations website at https://www.cognex.com/investor. The telephone number fo

    1/15/26 8:00:00 AM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    Cognex Reports Third Quarter 2025 Results

    NATICK, Mass., Oct. 29, 2025 /PRNewswire/ -- Cognex Corporation (NASDAQ:CGNX), the global technology leader in industrial machine vision, today reported financial results for the third quarter ended September 28, 2025. Third-Quarter Financial and Operating Highlights Revenue grew 18% year over year or 16% on a constant-currency basis.Excluding the one-time benefit from the commercial partnership with a medical lab automation channel partner (the "Commercial Partnership" or "CP"), revenue grew 13% year over year.Operating margin of 20.9%; Adjusted EBITDA margin of 24.9%, up 730

    10/29/25 4:30:00 PM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    $CGNX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Cognex Corporation

    SC 13G - COGNEX CORP (0000851205) (Subject)

    3/8/24 4:15:24 PM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G/A filed by Cognex Corporation (Amendment)

    SC 13G/A - COGNEX CORP (0000851205) (Subject)

    2/13/24 5:02:29 PM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G/A filed by Cognex Corporation (Amendment)

    SC 13G/A - COGNEX CORP (0000851205) (Subject)

    9/11/23 1:33:44 PM ET
    $CGNX
    Industrial Machinery/Components
    Industrials